Clik here to view.
InspireMD registers for $25m Series C
InspireMD (NYSE:NSPR) this week registered for a $24.8 million Series C round, with funding slated to support sales and new product development. The Boston-based company will offer 1.1 million shares...
View ArticleClik here to view.
InSitu Biologics touts preclinical data for non-opiate hydrogel painkiller
InSitu Biologics touted preclinical data for its non-opiate, hydrogel-based painkiller, AnestaGel, for use in peri-operative regional pain management. The St. Paul, Minn.-based company designs...
View ArticleClik here to view.
CeloNova touts study on Cobra PzF “nanocoated” coronary stents
CeloNova BioSciences yesterday released data from the Shield trial of its Cobra PzF nanocoated coronary stent, announcing the trial met its primary and secondary endpoints. Results from the study were...
View ArticleClik here to view.
Thermedical raises $3m for tissue ablation device
Thermedical raised $3 million in a new round of funding, according to regulatory filings. The private company is developing a treatment for ventricular tachycardia, an irregular heartbeat that can...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for January 25, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Vioguard raises $5m in Series A to support ultraviolet disinfection tech
Infection control device company Vioguard said today it raised $5 million in a Series A round of financing, with funds slated to support expanded sales and marketing and accelerated product...
View ArticleClik here to view.
Microscopic submarines release drugs depending on acid concentration
Researchers have developed tiny ‘submarines’ that speed through the stomach using gastric acid for fuel. The proton-driven micromotors have a pH-sensitive polymer coating that can be loaded with drugs...
View ArticleClik here to view.
Zimmer Biomet faces 14 cited observations in FDA form 483
The FDA recently released a Form 483 it issued to Zimmer Biomet (NYSE:ZBH) after inspecting its Warsaw, Ind.-based facilities, detailing 14 observations during its inspection. The 58-page document...
View ArticleClik here to view.
Neural Analytics wins CE Mark for next-gen Lucid transcranial ultrasound
Neural Analytics said today it won CE Mark approval in the European Union for its next-gen Lucid M1 transcranial doppler ultrasound system. The Los Angeles-based company’s Lucid M1 is a portable...
View ArticleClik here to view.
FDA delays final guidance plans for laboratory developed tests
By Stewart Eisenhart, Emergo Group US medical device regulators at the Food and Drug Administration have put on hold plans to publish final guidance regarding laboratory developed tests (LDTs) in order...
View ArticleClik here to view.
Abiomed’s Q3 numbers top estimates
Abiomed (NSDQ:ABMD) posted fiscal 3rd-quarter numbers this morning that beat the consensus estimates on Wall Street, sending share prices up in early trading. The Danvers, Mass.-based heart pump maker...
View ArticleClik here to view.
Women in medtech: Making gains but not there yet
Sarah Faulkner/Associate Editor When IBM Watson Health general manager Deborah DiSanzo, a 30-year medtech veteran, began as a project manager at Apollo Computer, there were plenty of women working...
View ArticleClik here to view.
Johnson & Johnson to pay $30B for Actelion
After weeks of exclusive negotiations, Johnson & Johnson (NYSE:JNJ) said on Thursday that it plans to buy Swiss biotech firm Actelion (VTX:ATLN) for $30 billion in an all-cash deal. The companies...
View ArticleClik here to view.
Judge extends block on HHS rule requiring disclosure of financial assistance...
A Texas federal judge today extended a block on a federal rule that would require dialysis providers to disclose any charitable assistance patients receive to insurers. The indefinite extension was...
View ArticleClik here to view.
Inside the largest medical acquisition in history
Heather Thompson/Senior Editor Trust between Medtronic and Covidien officials helped them overcome the political blowback from the two companies’ $50 billion merger of equals, which moved Medtronic’s...
View ArticleClik here to view.
Biogen beats Q4 earnings, misses on full-year rev forecast
Shares in Biogen (NSDQ:BIIB) rose this week after the biopharmaceutical company met expectations on Wall Street with its 4th quarter financial results, but pegged its full-year revenue forecast lower...
View ArticleClik here to view.
Cardiovascular Systems shares steady on Q2 beat
Shares in Cardiovascular Systems (NSDQ:CSII) have stayed steady today after the medical device maker posted 2nd quarter results which topped expectations on The Street. The St. Paul, Minn.-based...
View ArticleClik here to view.
FDA OKs Medtronic trial for In.Pact Admiral DCB in renal disease
Medtronic (NYSE:MDT) said today that the FDA approved its investigational device exemption application for a study to evaluate its In.Pact Admiral drug-coated balloon in patients with end-stage renal...
View ArticleClik here to view.
Medtronic wins CMS coverage for Micra leadless pacer
Medtronic (NYSE:MDT) said today the U.S. Centers for Medicare and Medicaid Services released a National Coverage Determination which will cover leadless cardiac pacemakers, including the company’s...
View ArticleClik here to view.
Verb Surgical debuts robot-assisted surgery prototype
Verb Surgical, Johnson & Johnson‘s (NYSE:JNJ) joint venture with Google parent Alphabet‘s (NSDQ:GOOGL) Verily Life Sciences, said today that it debuted its 1st digital surgery prototype to its...
View Article